Loading...
NPI 1790996882 · Exeter, NH · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Seacoast Pathology Inc is a clinical medical laboratory provider located in Exeter, New Hampshire. This profile covers 27 Medicare and 24 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Seacoast Pathology Inc |
| Address | 1 Hampton Rd Unit 307 |
| City | Exeter |
| State | NH |
| ZIP | 03833 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | May 24, 2007 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $1.4M |
| Medicaid | $994.8K |
SEACOAST PATHOLOGY INC operates as a high-volume clinical pathology laboratory with a clear mix of anatomic pathology and specialized staining/immunohistochemistry services on its Medicare panel. Its Medicare top performer is 88305 (30.5K claims, $853.7K revenue), a level IV surgical pathology code that alone accounts for 60.5% of this provider's total Medicare revenue, and the presence of high-volume antibody/stain codes such as 88312, 88341, and 88342 supports a workflow centered on surgical specimen processing and slide-based diagnostic interpretation. This pattern indicates primary revenue from diagnostic surgical pathology with substantial downstream immunohistochemical testing.
Revenue concentration is high for both payers: the provider's top 3 Medicare codes (88305, 88312, 88341) account for 78.3% of its Medicare revenue, and the top 3 Medicaid codes (87624, 88175, 88305) account for 68.8% of its Medicaid revenue. Those precomputed shares show the business is dependent on a small set of high-yield tests, which has implications for pricing negotiations, contract risk, and capacity planning if volumes shift for a few key codes.
The payer mix shows meaningful scale on both programs: total Medicare revenue is $1.4M while total Medicaid revenue is $994.8K, so the practice is not single-payer dependent and has substantial exposure to both Medicare and Medicaid populations. This dual-payer footprint suggests operational processes and billing capabilities that accommodate both federal and state laboratory programs.
On Medicare competitive standing, SEACOAST is a national outlier for its primary surgical pathology code: 88305 ranks #38 of 14580 providers nationally (100th percentile; extreme outlier), indicating volumes far above typical national peers for that service. Additional Medicare pathology/stain codes such as 88312 and 88341 rank in the 99th percentile and are described as notably above typical national volume, reinforcing a dominant procedural presence in surgical pathology at a national scale for these specific codes.
On Medicaid within New Hampshire, the provider is the clear state leader for high-volume cervical/HPV testing: 87624 (14K claims, $293K revenue) ranks #1 of 17 providers in-state (100th percentile; extreme outlier) and 88175 (14.6K claims, $292.1K revenue) also ranks #1 of 17 (100th percentile; extreme outlier). Those two codes each represent about 29% of the provider's Medicaid revenue, signaling that SEACOAST is functionally the top in-state destination for HPV and thin-layer cytology screening services.
Operational scale is evidenced by very large claim volumes across payers for a few codes: 30.5K Medicare claims for 88305 and Medicaid claim volumes of 14K for 87624 and 14.6K for 88175. These raw claim counts point to a high-throughput central laboratory model that likely processes community specimen sends and routine screening panels at scale.
The service mix shows breadth across diagnostic modalities: high Medicare revenue from surgical pathology and immunohistochemistry (88305, 88341, 88342) alongside high Medicaid volume for molecular/NAAT testing and cytology (87624, 88175, 87591, 87491). This combination indicates the lab provides both anatomic pathology interpretation services and high-throughput infectious disease/HPV molecular testing, which may support integrated offerings to outpatient clinics and public health programs.
SEACOAST PATHOLOGY's NPI was enumerated on 2007-05-24 (~19 years ago), reflecting long tenure in the market; combined with the labeled statistical positions (e.g., "extreme outlier" and "notably above typical") these patterns warrant attention from payers and competitors when evaluating contracting, network capacity, and referral relationships but do not on their own indicate any operational conclusion beyond large, concentrated test volumes.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
27 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 88305 | The physician, typically a pathologist, performs a level IV examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 30,490 | $30 | $853.7K |
| 88312 | The lab analyst performs the technical lab steps to stain a specimen with a special stain. This code applies to Group I for microorganisms. A qualified provider, typically a pathologist, interprets… | 1,910 | $70 | $133.6K |
| 88341 | The lab analyst applies an additional single antibody stain on a slide or slides prepared from the same patient specimen as the initial antibody stain, such as tumor tissue. Then a qualified… | 2,430 | $50 | $116.5K |
| 88342 | The lab analyst applies an initial single antibody stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. Then a qualified provider, typically a pathologist,… | 2,150 | $50 | $116.3K |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under… | 880 | $30 | $22.8K |
| 88112 | Selective cellular enhancement for cytopathology, such as the method of using a liquid–based slide preparation, uses a liquid–based medium to collect samples and preserve cells which can aid in… | 690 | $30 | $22.1K |
| 88304 | The physician, typically a pathologist, performs a level III examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 810 | $30 | $20.1K |
| 81513 | The lab analyst performs the technical lab test on a vaginal fluid specimen for quantitative real–time amplification of RNA markers for three bacterial species listed in the code descriptor, and… | 140 | $140 | $19.3K |
| G0416 | Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 120 | $150 | $17.3K |
| 88313 | The lab analyst performs the technical lab steps to stain a specimen for Group II identification, for example an iron stain or trichrome stain. A qualified provider, typically a pathologist,… | 270 | $60 | $15.6K |
Showing 1–10 of 27
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 27 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
24 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 87624 | The lab analyst performs a test to determine the presence of human papillomavirus, or HPV. The provider uses nucleic acid detection for high–risk types and produces a pooled result. | 13,950 | $20 | $293K |
| 88175 | The lab analyst performs the technical lab test to analyze a cervical or vaginal cytopathology specimen that a clinician collected in preservative fluid. The test uses automated thin layer… | 14,600 | $20 | $292.1K |
| 88305 | The physician, typically a pathologist, performs a level IV examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 6,160 | $20 | $104.8K |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 5,070 | $20 | $96.3K |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 4,860 | $20 | $92.4K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by… | 470 | $60 | $26.2K |
| 87661 | The lab analyst performs a test for Trichomonas vaginalis using nucleic acid amplified probe technique. | 780 | $20 | $15.5K |
| 87510 | The lab analyst performs a test for Gardnerella vaginalis using direct nucleic acid probe technique. Gardnerella vaginalis typically causes bacterial vaginosis, an infection of the vagina that… | 1,100 | $10 | $12.1K |
| 87660 | The lab analyst performs a test for Trichomonas vaginalis using direct nucleic acid probe technique. | 1,100 | $10 | $12.1K |
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 800 | $20 | $12K |
Showing 1–10 of 24
How this provider's Medicaid billing volume and revenue compare to other New Hampshire providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. New Hampshire median
24 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by… | 4 | 10 | 300 | $80 | $137.9K |
| 88305 | The physician, typically a pathologist, performs a level IV examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 6 | 40 | 1,000 | $30 | $92.2K |
| 88175 | The lab analyst performs the technical lab test to analyze a cervical or vaginal cytopathology specimen that a clinician collected in preservative fluid. The test uses automated thin layer… | 1 | 20 | 970 | $20 | $44K |
| 87624 | The lab analyst performs a test to determine the presence of human papillomavirus, or HPV. The provider uses nucleic acid detection for high–risk types and produces a pooled result. | 1 | 20 | 600 | $20 | $39.9K |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 4 | 30 | 890 | $20 | $38.9K |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 4 | 30 | 910 | $20 | $38.6K |
| 87661 | The lab analyst performs a test for Trichomonas vaginalis using nucleic acid amplified probe technique. | 4 | 10 | 210 | $30 | $26K |
| 87660 | The lab analyst performs a test for Trichomonas vaginalis using direct nucleic acid probe technique. | 2 | 10 | 450 | $10 | $13.3K |
| 88341 | The lab analyst applies an additional single antibody stain on a slide or slides prepared from the same patient specimen as the initial antibody stain, such as tumor tissue. Then a qualified… | 3 | 10 | 110 | $50 | $11.6K |
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 3 | 10 | 70 | $20 | $11.4K |
Showing 1–10 of 24
Other providers in the same ZIP code as Seacoast Pathology Inc, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.